Diligence memo · auto-generated · as of July 1, 2026
Starr Life Sciences Corp.
Starr Life Sciences Corp. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Starr Life Sciences Corp. operates in Other Health Care, based in OAKMONT.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Starr Life Sciences Corp. has raised $6.4M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.7M on 2010-10-12.
Most recent recorded round closed around 2010-10-12.
Valuation (modeled)modeled
Provath models Starr Life Sciences Corp. at approximately $92M (range $3.1M–$720M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.29× the median modeled value of Seed Other Health Care companies in 2010–2012 (243 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 15.7 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 9.7× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 69% of Other Health Care peers (5376 compared).
Modeled value ranks above 77% of those peers.
Closest niche peers: Coolsystems Inc, CuMed LLC, U.S. Nursing Corp, CMC II Investors, LLC, Kare Partners LLC.
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.